Enhancement of rat tear IgA antibody responses following intranasal immunization with antigen and CpG ODN

Current Eye Research

Volumn 24, Issue 3, 2002, Pages 228-233

  Gill, Randall F ^a   Montgomery, Paul C ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CpG oligodeoxynucleotides; IgA antibodies; Intranasal immunization; Microparticles; Tears

Indexed keywords

2,4 DINITROPHENOL; ANTIGEN; BOVINE SERUM ALBUMIN; IMMUNOGLOBULIN A ANTIBODY; OLIGODEOXYNUCLEOTIDE DERIVATIVE; POLYGLACTIN;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CPG ISLAND; FEMALE; IMMUNIZATION; IMMUNOMODULATION; LACRIMAL FLUID; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; SALIVA ANALYSIS;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES; ANTIGENS; CAPSULES; CPG ISLANDS; DINITROPHENOLS; DRUG COMBINATIONS; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN A; OLIGODEOXYRIBONUCLEOTIDES; RATS; RATS, INBRED F344; SERUM ALBUMIN, BOVINE; SOLUBILITY; TEARS;

EID: 0036401363     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.24.3.228.8298     Document Type: Article

References (32)

1. Montgomery PC, Whittum-Hudson J. Mucosal immunity in the ocular system. In: Kiyono H, Ogra PL, McGhee JR, eds. Mucosal Vaccines. New York: Academic Press; 1996:403-423.
2. nd Ed. New York: Academic Press; 1999:1241-1281.
3. Sullivan DA, Allansmith MR. Source of IgA in tears of rats. Immunology. 1984;53:791-799.
4. Peppard JV, Montgomery PC. Studies on the origin and composition of IgA in rat tears. Immunology. 1987;62:193-198.
5. Carr RM, Lolachi CM, Albaran RG, Ridley DM, Montgomery PC, O'Sullivan NL. Nasal-associated lymphoid tissue is an inductive site for rat tear IgA responses. Immunol Invest. 1996;25:387-396.
6. Ridley Lathers DM, Gill RF, Montgomery PC. Inductive pathways leading to rat tear IgA antibody responses. Invest Ophthalmol Vis Sci. 1998;39:1005-1011.
7. Staats HF, Montgomery SP, Palker TJ. Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responses. AIDS Res Hum Retroviruses. 1997;13:945-952.
8. Russell MW, Wu HY. Nasal-associated lymphoid tissue and mucosal vaccine development. Mucosal Immunol Update. 1997;5:12-14.
9. Rafferty DE, Elfaki MG, Montgomery PC. Preparation and characterization of a biodegradable microparticle antigen/cytokine delivery system. Vaccine. 1996;14:532-538.
10. Montgomery PC, Rafferty DE. Induction of secretory and serum antibody responses following oral administration of antigen with bioadhesive degradable starch microparticles. Oral Microbiol Immunol. 1998;13:139-149.
11. Pockley AG, Montgomery PC. In vivo adjuvant effect of interleukins 5 and 6 on rat tear IgA antibody responses. Immunology. 1991;73:19-23.
12. Lillard JW, Boyaka PN, Taub DD, McGhee JR. RANTES potentiates antigen-specific mucosal immune responses. J Immunol. 2001;166:162-169.
13. Wu H-Y, Russell MW. Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant. Vaccine. 1998;16:286-292.
14. Frey A, Giannasca KT, Weltzin R, Giannasca PJ, Reggio H, Lencer WI, Neutra MR. Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: Implications of microbial attachment and oral vaccine targeting. J Exp Med. 1996;184:1045-1059.
15. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 1995;374:546-549.
16. Jones TR, Obaldia III N, Gramzinski RA, Charoenvit Y, Kolodny N, Davis HL, Krieg AM, Hoffman SL. Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys. Vaccine. 1999;17:3065-3071.
17. Davis HL, Weeratna R, Waldschmidt TJ, Tygrett L, Schorr J, Kreig AM. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol. 1998;160:870-876.
18. Klinman DM, Yi AK, Beaucage SL, Conover J, Krieg AM. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12 and interferon gamma. Proc Natl Acad Sci USA. 1996;93: 2879-2883.
19. McCluskie MJ, Weeratna RD, Clements JD, Davis HL. Mucosal immunization of mice using CpG DNA and/or mutants of heat-labile enterotoxin of Escherichia coli as adjuvants. Vaccine. 2001;19:3759-3768.
20. McCluskie MJ, Davis HL. CpG DNA as mucosal adjuvant. Vaccine. 2000;18:231-237.
21. McCluskie MJ, Weeratna RD, Krieg AM, Davis HL. CpG DNA is an effective oral adjuvant to protein antigens in mice. Vaccine. 2000;18:950-957.
22. Webb A, Cunningham D, Cotter F, Clark PA, Di Stefano F, Ross P, Corbo M, Dziewanowska Z. BCL-2 antisense therapy in patients with non-Hodgkins lymphoma. Lancet. 1997;349:1137-1141.
23. Eisen HN. Preparation of purified anti-2,4-dinitrophenyl antibodies. Methods Med Res. 1964;10:94-102.
24. Jeffery H, Davis SS, O'Hagen DT. The preparation and characterization of poly(lactide-co-glycolide) microparticles. II: the entrapment of the model protein using a (water-in-oil)-water emulsion solvent evaporation technique. Pharmacol Res. 1993;10:362-368.
25. Davis HL, Suparto I, Weeratna R, Jumintarto, Iskandriati D, Chamzah S, Ma'ruf A, Nente C, Pawitri D, Krieg AM, Heriyanto, Smits W, Sajuthi D. CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans. Vaccine. 2000;18:1920-1924.
26. Eastcott JW, Holmberg CJ, Dewhirst FE, Esch TR, Smith DJ, Taubman MA. Oligonucleotide containing CpG motifs enhances immune response to mucosally or systemically administered tetanus toxoid. Vaccine. 2001;19:1636-1642.
27. Moldoveanu Z, Love-Homan L, Huang WQ, Krieg AM. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine. 1998;16:1216-1224.
28. Wu HY, Nguyens HH, Russell MW. Nasal lymphoid tissue (NALT) as a mucosal immune inductive site. Scand J Immunol. 1997;46:506-513.
29. Spit BJ, Hendriksen EGJ, Bruijntjes JP, Kuper CF. Nasal lymphoid tissue in the rat. Cell Tissue Res. 1989;255:193-198.
30. Zhao Q, Matson S, Herrara C, Fisher E, Yu H, Waggoner A, Krieg AM. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides. Antisense Res Dev. 1993;3:53-66.
31. Oh YK, Kim JP, Hwang TS, Ko JJ, Kim JM, Yang JS, Kim CK. Nasal absorption and biodistribution of plasmid DNA: An alternative route of DNA vaccine delivery. Vaccine. 2001;19:4519-4525.
32. Jakob T, Walker PS, Krieg AM, Udey MC, Vogel JC. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: A role for dendritic cells in the augmentation of Th1 response by immunostimulatory DNA. J Immunol. 1998;161:3042-3049.